Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-24-047695

VP of Research and Development bought 200 shares at $1.59 ($318)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Murali Ramachandran VP of Research and Development 2024-11-25 Purchase +200 $1.59 $318 133,057 D
Open-market purchases · 200 sh · avg $1.59 · $318
Loading xslF345X05/ownership.xml…